What is it about?
Type-2 diabetes mellitus (T2DM) is responsible for at least 90% of all cases of diabetes mellitus, and it barely occurs without associated conditions of heart and vascular related problems. Over the years, systematic measurements of size, shape and composition (especially body mass index and waist circumference) of the human body has been used alongside routine fasting glucose measurement as a marker for individual cardiovascular risk stratification and subsequent decision for primary prevention in Ghana. LAP represent a useful tool for screening cardiometabolic risk factors and has proven superior over waist circumference and body mass index that is routinely used in Ghana.
Featured Image
Why is it important?
The usefulness of LAP as a surrogate marker for cardiovascular risk has not been explored in Ghana, especially in resource limited settings for decision-making in terms of prevention. Thus, this research paper opens the usefulness and applicability of LAP index among T2DM patients in Ghana and evidence for future investigations. Being a reliable indicator and a surrogate marker, LAP saves patients the cost of further expensive metabolic profile test and a decision tool for primary preventive strategies.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations.
Mr Evans Asamoah Adu
Read the Original
This page is a summary of: Lipid accumulation product (LAP) index as a potential risk assessment for cardiovascular risk stratification among type II diabetes mellitus in a Ghanaian population: A cross-sectional study, Cogent Medicine, July 2019, Taylor & Francis,
DOI: 10.1080/2331205x.2019.1639880.
You can read the full text:
Resources
Contributors
The following have contributed to this page
